| Fernando Espi Forcen, | |
|
2150w Harrison St, Chicago, IL 60612-3706 | |
| (312) 942-5375 | |
| Not Available |
| Full Name | Fernando Espi Forcen |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 19 Years |
| Location | 2150w Harrison St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003049792 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 036-130030 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
| The Mclean Hospital Corporation | 9436040961 | 139 |
News Archive
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
President Obama's support for his signature health care act took a fresh hit Friday. The Catholic Health Association, the nation's largest private health care provider, has rebuffed the latest White House moves to make its contraception coverage mandate more acceptable to Catholics and conservative evangelicals, according to Religion News Service.
The independent Africa Regional Certification Commission for Polio Eradication officially declared on Tuesday that the World Health Organization African Region is free of wild poliovirus.
Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.
› Verified 5 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
President Obama's support for his signature health care act took a fresh hit Friday. The Catholic Health Association, the nation's largest private health care provider, has rebuffed the latest White House moves to make its contraception coverage mandate more acceptable to Catholics and conservative evangelicals, according to Religion News Service.
The independent Africa Regional Certification Commission for Polio Eradication officially declared on Tuesday that the World Health Organization African Region is free of wild poliovirus.
Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.
› Verified 5 days ago
| Entity Name | The Mclean Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114979580 PECOS PAC ID: 9436040961 Enrollment ID: O20040323001228 |
News Archive
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
President Obama's support for his signature health care act took a fresh hit Friday. The Catholic Health Association, the nation's largest private health care provider, has rebuffed the latest White House moves to make its contraception coverage mandate more acceptable to Catholics and conservative evangelicals, according to Religion News Service.
The independent Africa Regional Certification Commission for Polio Eradication officially declared on Tuesday that the World Health Organization African Region is free of wild poliovirus.
Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.
› Verified 5 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
President Obama's support for his signature health care act took a fresh hit Friday. The Catholic Health Association, the nation's largest private health care provider, has rebuffed the latest White House moves to make its contraception coverage mandate more acceptable to Catholics and conservative evangelicals, according to Religion News Service.
The independent Africa Regional Certification Commission for Polio Eradication officially declared on Tuesday that the World Health Organization African Region is free of wild poliovirus.
Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fernando Espi Forcen, 2150w Harrison St, Chicago, IL 60612-3706 Ph: (312) 942-5375 | Fernando Espi Forcen, 2150w Harrison St, Chicago, IL 60612-3706 Ph: (312) 942-5375 |
News Archive
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
President Obama's support for his signature health care act took a fresh hit Friday. The Catholic Health Association, the nation's largest private health care provider, has rebuffed the latest White House moves to make its contraception coverage mandate more acceptable to Catholics and conservative evangelicals, according to Religion News Service.
The independent Africa Regional Certification Commission for Polio Eradication officially declared on Tuesday that the World Health Organization African Region is free of wild poliovirus.
Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.
› Verified 5 days ago
Andrea Catalina Pardo, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 225 E Chicago Ave # 51, Chicago, IL 60611 Phone: 312-227-3550 | |
Moanis Karam Hilmy Bastawrous, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3003 Green Bay Road, Chicago, IL 60064 Phone: 347-228-8628 | |
Bernadette Mari Schoneburg, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 17 25 West Harrison Street, Professional Building I Suite 1106, Chicago, IL 60612 Phone: 312-942-5000 | |
Dr. Neepa J Patel, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 755, Chicago, IL 60612 Phone: 312-563-2030 Fax: 312-563-2024 | |
Dr. Marley Ann Doyle, M/D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St, Galter 3-150, C, Chicago, IL 60611 Phone: 312-926-6895 | |
Dr. David Eugene Klein, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 259 E Erie St Fl 19, Chicago, IL 60611 Phone: 312-695-7950 Fax: 312-695-5747 |